Tenaya Therapeutics Inc (TNYA) Live Share Price, Invest From India

Tenaya Therapeutics Inc Stock Performance

as on June 12, 2026 at 2:16 pm IST

Day's Low
Day's High
$0.68
Day's Price Range
$0.71
$0.72
5.56%
Downside
-1.39%
Upside
52 Week's Low
52 Week's High
$0.53
52-Week Price Range
$2.35
$0.72
26.17%
Downside
226.39%
Upside

Tenaya Therapeutics Inc share price movements today

Previous Close: $0.70
Open: $0.69
Volume: 2.8M
Day's Low - High: $0.68 - $0.71
52 Week Low - High: $0.53 - $2.35

Tenaya Therapeutics Inc Historical Returns

1 Month Return: -28.02 %
3 Month Return: -19.39 %
1 Year Return: + 19.81 %
3 Year Return: -89.64 %
5 Year Return: 0 %

Tenaya Therapeutics Inc Stock Fundamentals & Key Indicators

Check Tenaya Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$149.1M

EPS (TTM)

-0.3825

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-78.3M

Revenue (TTM)

225.0K

Profit Margin

0.00%

Return On Equity TTM

-73.59%

Tenaya Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tenaya Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Tenaya Therapeutics Inc	BUY	$149.1M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc	BUY	$39.7B	75.37%	74.61	12.55%	NA
Vertex Pharmaceuticals Inc	BUY	$113.1B	130.57%	26.46	35.51%	NA
Regeneron Pharmaceuticals Inc	BUY	$64.6B	16.35%	15.04	29.65%	0.59%

Stock Returns calculator for Tenaya Therapeutics Inc Stock including INR - Dollar returns

The Tenaya Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Tenaya Therapeutics Inc investment value today

Current value as on today

₹1,34,451

Returns

₹34,451

(+34.45%)

Returns from Tenaya Therapeutics Inc Stock

₹20,000 (+20%)

Dollar Impact

₹14,451 (+14.45%)

Analyst Recommendation on Tenaya Therapeutics Inc Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Tenaya Therapeutics Inc. Average target price of $4

Tenaya Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Tenaya Therapeutics Inc.

What analysts predicted

82%UPSIDE

Target Price

Current Price

$0.72

Analyzed by

14 Analysts

Target

$4.00

Tenaya Therapeutics Inc target price $4, a slight upside of 82% compared to current price of $0.72. According to 14 analysts rating.

Indian Investors' Interest in Tenaya Therapeutics Inc Stock

Investment in Tenaya Therapeutics Inc Shares on INDmoney has grown by 27.08% in the last 30 days, indicating increased investment activity.

Time period: May 13, 2026 to June 12, 2026

Change:27.08% versus previous 30 day period

Search interest for Tenaya Therapeutics Inc Stock has increased by 89% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 13, 2026 to June 12, 2026

Change:89% versus previous 30 day period

Tenaya Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	17	-	-	-	-	-	-	-	-	0
Gross Profit	-2	-2	-2	-	-	-	-2	-1	3	-1
Operating Income	-31	-33	-30	-26	-24	-27	-24	-20	-20	-20
EBITDA	-26	-30	-27	-24	-22	-24	-21	-19	-18	-18
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	2	2	2	2	2	2	2	1	1	1
Income Before Tax	-29	-32	-29	-25	-23	-26	-23	-20	-20	-19
Income Tax Expense	2	2	-	-	-	-	-	-	-	-
Net Income	-29	-32	-29	-25	-23	-26	-23	-20	-20	-19
Net Profit Margin	-169.47%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-8565.33%

Tenaya Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-1	-2	-4	-8	-8	-8	-8
Operating Income	-27	-38	-72	-125	-131	-115	-93
EBITDA	-25	-35	-69	-119	-115	-102	-84
Interest Expense	-	-	72	0	-	-	-
Depreciation	1	2	2	6	8	8	8
Income Before Tax	-26	-38	-72	-123	-124	-111	-90
Income Tax Expense	0	0	-3	0	8	-111	-
Net Income	-25	-38	-69	-123	-124	-111	-90
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Tenaya Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-32	-29	-25	-23	-26	-23	-20	-20	-19
Operating Cash Flow	-28	-23	-19	-18	-23	-15	-15	-13	-19
Investing Cash Flow	-4	21	-30	14	22	24	8	0	0
Financing Cash Flow	46	0	0	0	50	0	0	58	0
Change in Cash	13	-1	-49	-3	49	8	-6	44	-19

Tenaya Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-38	-72	-123	-124	-111	-90
Operating Cash Flow	-35	-60	-104	-102	-90	-68
Investing Cash Flow	-7	-238	83	48	1	56
Financing Cash Flow	147	208	77	4	47	108
Change in Cash	104	-90	56	-49	-41	96

Global Institutional Holdings in Tenaya Therapeutics Inc

Funds	Holdings
Euclidean Capital LLC	0.47%
Alyeska Investment Group, L.P.	1.84%
Kalehua Capital Management LLC	1.84%
Marshall Wace Asset Management Ltd	1.25%
Geode Capital Management, LLC	0.72%

See all

Insights on Tenaya Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, TNYA has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Tenaya Therapeutics, Inc. Common Stock has experienced a drawdown of -89.6%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 70.7%
NEGATIVE IMPACT
Price Dip
In the last 1 month, TNYA stock has moved down by -28.0%

About Tenaya Therapeutics Inc

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. The company develops its products through gene addition, gene editing, gene silencing, and cellular regeneration. It has a research collaboration agreement with Alnylam Pharmaceuticals, Inc. to identify and validate novel gene targets for the potential treatment of cardiovascular disease. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Organisation	Tenaya Therapeutics Inc
Headquarters	171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Industry	Biotechnology
CEO	Mr. Faraz Ali M.B.A.
E-voting on shares	Click here to vote

Key Management of Tenaya Therapeutics Inc

Name	Title
Mr. Faraz Ali M.B.A.	CEO, Interim Principal Financial Officer & Director
Dr. Deepak Srivastava M.D.	Scientific Founder, Chairman of Scientific Advisory Board & Director
Dr. Saptarsi Haldar M.D.	Scientific Founder
Dr. Kee-Hong Kim Ph.D.	Chief Technology Officer
Dr. Whittemore G. Tingley M.D., PH.D.	Chief Medical Officer
Dr. Eric N. Olson Ph.D.	Scientific Founder & Member of Scientific Advisory Board
Dr. Bruce R. Conklin M.D.	Scientific Founder
Dr. Sheng Ding Ph.D.	Scientific Founder
Dr. Benoit G. Bruneau Ph.D.	Scientific Founder
Mr. Tomohiro Higa M.B.A.	Senior Vice President of Finance & Interim Principal Accounting Officer

FAQs

What is Tenaya Therapeutics Inc share price today?

Tenaya Therapeutics Inc share price today is $0.72 as on June 12, 2026 at 8:46 am IST at the close of the market. Tenaya Therapeutics Inc share today touched a day high of $0.71 and a low of $0.68.

What is the 52 week high and 52 week low for Tenaya Therapeutics Inc share?

Tenaya Therapeutics Inc share touched a 52 week high of $2.35 on October 10, 2025 and a 52 week low of $0.53 on March 3, 2026. Tenaya Therapeutics Inc stock price today i.e. June 12, 2026 at 8:46 am IST is closed at $0.72,which is 69.36% down from its 52 week high and 35.44% up from its 52 week low.

What is Tenaya Therapeutics Inc's market capitalisation today?

Tenaya Therapeutics Inc market capitalisation is $0.00T as on June 12, 2026 at 8:46 am IST.

How to invest in Tenaya Therapeutics Inc Stock (TNYA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tenaya Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tenaya Therapeutics Inc Shares that will get you 2.0833 shares as per Tenaya Therapeutics Inc share price of $0.72 per share as on June 12, 2026 at 8:46 am IST.

What is the minimum amount required to buy Tenaya Therapeutics Inc Stock (TNYA) from India?

Indian investors can start investing in Tenaya Therapeutics Inc (TNYA) shares with as little as ₹95.76 or $1 (as of June 12, 2026 at 12:45 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.60 in Tenaya Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on June 12, 2026 at 12:45 pm IST). Based on Tenaya Therapeutics Inc share’s latest price of $0.72 as on June 12, 2026 at 8:46 am IST, you will get 13.8889 shares of Tenaya Therapeutics Inc. Learn more about fractional shares .